Clinical Trials Directory

Trials / Unknown

UnknownNCT03963076

Efficacy of Nasal Spray Hypertonic Puressentiel on Symptoms of Allergic Rhinitis

Evaluation of the Efficiency of Nasal Spray Hypertonic Puressentiel on Symptoms of Patients With Allergic Rhinitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Puressentiel · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Prospective multicentric study. 60 subjects with allergic rhinitis will be enrolled to test the efficacy of nasal hypertonic spray Puressentiel on symptoms of allergic rhinitis and nasal peak flow. Subjects with allergic rhinitis and nasal obstruction will use during 30 days the nasal spray (2 nebulisations /day in each nostril) during 30 days. Rhinitis symptoms questionnaire and nasal inspiratory peak flow will be evaluated before and after 30 days of exposure.

Detailed description

Objective: evaluate the efficiency of a nasal hypertonic spray Puressentiel in subjects with allergic rhinitis and nasal obstruction. Inclusion criteria: subjects with allergic obstructive rhinitis without treatment or remaining symptomatic despite treatment. Duration of exposure: 2 nasal sprays per day (morning and evening) during 30 months. Primary criteria of efficacy: Rhinitis questionnaire. Secondary criteria: Inspiratory nasal peak flow

Conditions

Interventions

TypeNameDescription
OTHERnasal hypertonic spray: combination of hypertonic sea water and organic rosemary floral water with essential oils (ravintsara, geranium, eucalyptus radiata, niaouli)One spray of nasal hypertonic spray morning and evening every day during 30 days

Timeline

Start date
2019-05-01
Primary completion
2019-09-30
Completion
2019-10-31
First posted
2019-05-24
Last updated
2019-05-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03963076. Inclusion in this directory is not an endorsement.